Document Detail


Higher incidence of injection site reactions after subcutaneous bortezomib administration on the thigh compared with the abdomen.
MedLine Citation:
PMID:  23240903     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Subcutaneous (sc) rather than intravenous administration of bortezomib (Bor) is becoming more common for treating multiple myeloma (MM) because scBor results in lower incidence and severity of peripheral neuropathy and has equivalent efficacy. Bor is an irritant cytotoxic agent when it leaks out; therefore, it is recommended that injections of scBor should be rotated among 8 different sites on the abdomen and thigh. However, detailed information about injection site reactions (ISR) have not been sufficiently documented. We retrospectively analyzed the incidence and severity of ISR following scBor administration in 15 Japanese patients with MM. Grade 1 ISR occurred following 40 of 158 (25.3%) scBor injections in 10 patients, whereas grade 2 ISRs occurred following 7 injections (4.4%) in 5 patients. Five patients did not develop ISR. Of note, grade 2 ISR was documented in 6 of 65 (9.2%) thigh injections but only in 1 of 93 (1.1%) abdominal injections. These data show that grade 2 ISR were more common in the thigh compared with the abdomen possibly because the thigh contains lesser adipose tissue than the abdomen. Grade 2 ISRs resolved without any sequela within a median of 7 days. scBor administration on the abdomen instead of the thigh should be considered, especially for emaciated patients, because ISR rapidly resolves within the interval before the next injection even if it occurs. © 2012 John Wiley & Sons A/S.
Authors:
Tomohiko Kamimura; Toshihiro Miyamoto; Noriko Yokota; Shuichiro Takashima; Yong Chong; Yoshikiyo Ito; Koichi Akashi
Related Documents :
10922163 - Use of a resorbable fixation system in orthognathic surgery.
12637903 - Long-term effects of class iii treatment with rapid maxillary expansion and facemask th...
18356443 - Fluoroscopic intralesional injection with pingyangmycin lipiodol emulsion for the treat...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-14
Journal Detail:
Title:  European journal of haematology     Volume:  -     ISSN:  1600-0609     ISO Abbreviation:  Eur. J. Haematol.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8703985     Medline TA:  Eur J Haematol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 John Wiley & Sons A/S.
Affiliation:
Department of Hematology, Harasanshin Hospital, Fukuoka, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Factors influencing the adoption and implementation of teledentistry in the UK, with a focus on orth...
Next Document:  Effect of positive emotion on consolidation of memory for faces: The modulation of facial valence an...